VAXGEN INC. (VXGN)- The IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VAXGEN INC. (VXGN)- The IPO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Manfred Sondermann who wrote (35)	7/12/1999 9:03:00 AM
From: gary r. albrecht	Read Replies (1) of 55

Manfred, I think you are correct in that Genentech is the holder of the patents. However, Vaxgen has an exclusive license from Genetech to the patents. Genentech can terminate the license agreement under certain non-performance clauses. GPSite, I realize that statistical results from those vaccinated in Phases I and II would not be valid for use by the FDA. I am only speaking with regard to my investment comfort level. If I knew that not one of the 2000 vaccinated have become infected with HIV my comfort level would be greater, that is all I'm getting at. gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next